Entity Common Stock, Shares Outstanding of IRONWOOD PHARMACEUTICALS INC from 12 Feb 2019 to 31 Jan 2026

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
IRONWOOD PHARMACEUTICALS INC quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 12 Feb 2019 to 31 Jan 2026.
  • IRONWOOD PHARMACEUTICALS INC Entity Common Stock, Shares Outstanding for the quarter ending 31 Jan 2026 was 163,058,316.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

IRONWOOD PHARMACEUTICALS INC Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 163,058,316 31 Jan 2026 10-K 26 Feb 2026 2025 FY
Q3 2025 162,678,647 +2,650,259 +1.7% 31 Oct 2025 10-Q 10 Nov 2025 2025 Q3
Q2 2025 162,434,130 +2,695,129 +1.7% 31 Jul 2025 10-Q 11 Aug 2025 2025 Q2
Q1 2025 161,819,848 +2,862,725 +1.8% 30 Apr 2025 10-Q 12 May 2025 2025 Q1
Q3 2024 160,028,388 +3,899,342 +2.5% 31 Oct 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 159,739,001 +3,709,815 +2.4% 31 Jul 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 158,957,123 +3,611,020 +2.3% 30 Apr 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 156,528,648 +2,370,602 +1.5% 31 Jan 2024 10-K 16 Feb 2024 2023 FY
Q3 2023 156,129,046 +2,733,569 +1.8% 31 Oct 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 156,029,186 +2,798,056 +1.8% 31 Jul 2023 10-Q 09 Aug 2023 2023 Q2
Q1 2023 155,346,103 +1,508,237 +0.98% 30 Apr 2023 10-Q 04 May 2023 2023 Q1
Q4 2022 154,158,046 -5,063,923 -3.2% 31 Jan 2023 10-K 16 Feb 2023 2022 FY
Q3 2022 153,395,477 -10,255,010 -6.3% 31 Oct 2022 10-Q 03 Nov 2022 2022 Q3
Q2 2022 153,231,130 -9,663,881 -5.9% 31 Jul 2022 10-Q 04 Aug 2022 2022 Q1
Q1 2022 153,837,866 -8,128,871 -5% 30 Apr 2022 10-Q 05 May 2022 2022 Q1
Q4 2021 159,221,969 -1,740,206 -1.1% 31 Jan 2022 10-K 18 Feb 2022 2021 FY
Q3 2021 163,650,487 +3,553,373 +2.2% 31 Oct 2021 10-Q 04 Nov 2021 2021 Q3
Q2 2021 162,895,011 +2,916,874 +1.8% 31 Jul 2021 10-Q 05 Aug 2021 2021 Q2
Q1 2021 161,966,737 +2,588,100 +1.6% 30 Apr 2021 10-Q 06 May 2021 2021 Q1
Q4 2020 160,962,175 +2,755,263 +1.7% 10 Feb 2021 10-K 17 Feb 2021 2020 FY
Q3 2020 160,097,114 +3,278,988 +2.1% 02 Nov 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 159,978,137 +3,482,563 +2.2% 03 Aug 2020 10-Q 06 Aug 2020 2020 Q2
Q1 2020 159,378,637 +3,757,332 +2.4% 01 May 2020 10-Q 06 May 2020 2020 Q1
Q4 2019 158,206,912 +3,561,652 +2.3% 10 Feb 2020 10-K 13 Feb 2020 2019 FY
Q3 2019 156,818,126 25 Oct 2019 10-Q 31 Oct 2019 2019 Q3
Q2 2019 156,495,574 26 Jul 2019 10-Q 30 Jul 2019 2019 Q2
Q1 2019 155,621,305 30 Apr 2019 10-Q 02 May 2019 2019 Q1
Q4 2018 154,645,260 12 Feb 2019 10-K 25 Feb 2019 2018 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.